Pathologic basis of the symptomatic epilepsies in childhood

Journal of Child Neurology

Volumn 13, Issue 8, 1998, Pages 361-371

  Armstrong, Dawna Duncan ^a   Mizrahi, Eli M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGYRIA; BENIGN CHILDHOOD EPILEPSY; BRAIN HEMORRHAGE; CHILD; DISEASE CLASSIFICATION; GENETIC ANALYSIS; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIC CELL; MOYAMOYA DISEASE; NEUROPATHOLOGY; PHAKOMATOSIS; PRIORITY JOURNAL; REVIEW; STURGE WEBER SYNDROME; TUBEROUS SCLEROSIS;

EID: 0031707405     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389801300801     Document Type: Review

References (114)

1. Sutula T: The pathologies of the epilepsies: Insights into the causes and consequences of epileptic syndromes, in Dodson WE, Pellock JM (eds): Pediatric Epilepsy: Diagnoses and Therapy. New York, Demos Publications, 1993, pp 37-43.
2. Lothman EW: Pathophysiology of seizures and epilepsy in the mature and immature brain: Cells, synapses, and circuits, in Dodson WE, Pellock JM (eds): Pediatric Epilepsy: Diagnosis and Therapy. New York, Demos Publications, 1993, pp 1-15.
3. DeLorenzo RJ: Ion channels, membranes, and molecules in understanding epilepsy and neuronal excitability, in Dodson WE, Pellock JM (eds): Pediatric Epilepsy: Diagnosis and Therapy. New York, Demos Publications, 1993, pp 17-25.
4. Engel J Jr: New concepts of the epileptic focus in Wieser HG, Speckmann EJ, Engel J Jr (eds): Current Problems in Epilepsy, vol. 3. The Epileptic Focus. London, John Libbey, 1987, pp 83-94.
5. International League Against Epilepsy, Commission 1989. Epilepsia 1989;30:389-399.
6. Hauser WA: Seizure disorders: The changes with age. Epilepsia 1992;33(Suppl):S6-S14.
7. Lyon G, Gastaut H: Considerations on the significance attributed to unusual cerebral histological findings recently described in eight patients with primary generalized epilepsy. Epilepsia 1985; 26:365-367.
8. Barth PG: Disorders of neuronal migration. Can J Neurol Sci 1987;14:1-16.
9. Hatten ME, Mason CA: Mechanisms of glial-guided neuronal migration in vitro and in vivo. Experientia 1990;46:907-916.
10. Rakic P: Specification of cerebral cortical areas. Science 1988;241:170-176.
11. Walsh C, Cepko CL: Cell lineage and cell migration in the developing cerebral cortex. Experientia 1990;46:940-947.
12. Shaw CM, Alvord EC: Hydrocephalus, in Duckett S (ed): Pediatric Neuropathology. Baltimore, Williams & Wilkins, 1995, pp 179-184.
13. Hanaway J, Lee SL, Netsky MG: Pachygyria: Relation of findings to modern embryologic concepts. Neurology 1968;18:791-799.
14. Stewart RM, Richman DP, Caviness VS Jr: Lissencephaly and pachygyria: An architecture and topographical analysis. Acta Neuropathol 1975;31:1-12.
15. Miller JQ: Lissencephaly in two siblings. Neurology 1963;13:841-850.
16. Dieker H, Edwards RH, Zurhein G, et al: The lissencephalic syndrome. Birth Defects 1969;5:53-64.
17. Friede RL: Developmental Neuropathology. Berlin, Springer-Verlag, 1989, pp 330-332.
18. Dobyns WB, Curry CJR, Hoyme HE, et al: Clinical and molecular diagnosis of Miller-Dieker Syndrome. Am J Hum Genet 1991;48:584-594.
19. Van Allen M, Clarren SK: A spectrum of gyral anomalies in MillerDieker (Lissencephaly) Syndrome. J Pediatr 1983;102:559-564.
20. Volpe JJ: Neurology of the Newborn. Philadelphia, WB Saunders, 1995.
21. Dobyns WB, Truwit CL: Lissencephaly and other malformations of cortical development: Update. Neuropediatrics 1995;26:132-147.
22. Williams RS, Ferrante RJ, Caviness VS Jr: The cellular pathology of microgyria. A golgi analysis. Acta Neuropathol 1976;36:269-283.
23. Chan CC, Egbert PR, Herrick MK, Urich H: Oculocerebral malformations a reappraisal of Walker's "lissencephaly." Arch Neurol 1980;37:104-108.
24. Gelot A, Billette de Villemeur T, Bordarier C, et al: Developmental aspects of type II lissencephaly: Comparative study of dysplastic lesions in fetal and post-natal brains. Acta Neuropathol 1995;89:72-84.
25. Lyon G, Raymond G, Mogami K, et al: Disorder of cerebellar foliation in Walker's lissencephaly and Neu-Laxova syndrome. J Neuropathol Exp Neurol 1993;52:633-639.
26. Towfighi J, Sassni JW, Suzuki K, Ladda RL: Cerebro-ocular dysplasia-muscular dystrophy (COD-MD) syndrome. Acta Neuropathol 1984;65:110-123.
27. Leyton QH, Renkawek K, Renier WO, et al: Neuropathological findings in muscle-eye-brain disease (MEB-D). Acta Neuropathol 1991;83:55-60.
28. Dobyns WB: Classification of the cerebro-ocular muscular syndrome-commentary. Brain Dev 1993;15:242-244.
29. Fukuyama Y, Osawa M, Suzuki J: Congenital progressive muscular dystrophy of the Fukuyama type; clinical, genetic and pathological considerations. Brain Dev 1981;3:1-29.
30. Gressens P, Lammens M, Piccard JJ, Evrard P: Ethanol induced disturbances of glioneogenesis and neurogenesis in the developing murine brain: An in vitro and in vivo immunohistochemical and ultrastructural study. Alcohol 1992;27:219-226.
31. Spohr HL, Willms J, Steinhausen C: Prenatal alcohol exposure and long term developmental consequences. Lancet 1993;341:907-910.
32. Clarren SL, Alvord EC, Sumi I: Brain malformations related to prenatal exposure to ethanol. J Pediatr 1978;26:132-147.
33. Bankl H, Jellinger K: Central nervous system injuries following fetal carbon monoxide poisoning. Beitr Pathol Anat 1967;135:350-376.
34. Freide RL, Mikolasek J: Postencephalitis porencephaly, hydranencephaly or polymicrogyria. A review. Acta Neuropathol 1978;43:161-168.
35. Taylor DC, Falconer MA, Bruton CJ, Corsellis JAN: Focal dysplasia of the cerebral cortex in epilepsy. J Neural Neurosurg Psychiatry 1971;34:369-387.
36. Robinson RO: Familial schizencephaly. Dev Med Child Neurol 1991;33:1010-1012.
37. Barckovich AJ, Kjos BO: Schizencephaly: Correlation of clinical findings with MR characteristics. AJNR Neuroradiol 1992;13:85-94.
38. Vinters HV, Fisher RS, Cornford ME, et al: Morphological substrates of infantile spasms: Studies based on surgically resected cerebral tissue. Childs Nerv Syst 1992;8:8-18.
39. Mischel PS, Nguyen LP, Vinters HV: Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neural 1995;54:137-153.
40. Palmini A, Andermann F, Olivier A, et al: Focal neuronal migration disorders and intractable partial epilepsy: A study of 30 patients. Ann Neurol 1991;30:712-749.
41. Daumas-Duport C: Patterns of tumor growth and problems associated with histological typing of low grade gliomas, in Apuzzo MLJ (ed): Benign Cerebral Glioma, vol 1. Park Ridge, American Association of Neurological Surgeons, 1995, pp 125-148.
42. Kuzniecky R, Andermann F, Guerrini R: Infantile spasms: An early epileptic manifestation in some patients with the congenital bilateral perisylvian syndrome. J Child Neurol 1994;9:420-423.
43. Foix C, Chavany JA, Marie J: Diplegie facio-linguo-masticatrice d'origine cortico-sous-cortical sans paralysie des members. Rev Neurol 1926;33:214-219.
44. Pinard JM, Mathe J, Chirin C, et al: Subcortical laminar heterotopic and lissencephaly in two families: A single X-linked dominant gene. J Neurol Neurosurg Psychiatry 1994;57:914-920.
45. Maloof J, Sledz K, Hogg JP, et al: Unilateral megalencephaly and tuberous sclerosis: Related disorders? J Child Neurol 1994;9:443-446.
46. Bignami A, Palladini G, Zappella M: Unilateral megalencephaly with nerve cell hypertrophy: An anatomical and quantitative histochemical study. Brain Res 1968;9:103-114.
47. Manz HJ, Phillips TM, Rowden G, McCullough DC: Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: Cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol 1979;45:97-103.
48. Meenke HJ, Janz D: The significance of microdysgenesis in primary generalized epilepsy: An answer to the considerations of Lyon and Gastaut. Epilepsia 1985;26:368-371.
49. Hardiman O, Burke T, Phillips J: Microdysgenesis in resected temporal neocortex: Incidence and clinical significance in focal epilepsy. Neurology 1988;38:1041-1047.
50. Armstrong DD, Bruton CJ: Postscript: What terminology is appropriate for tissue pathology? How does it predict outcome? in Engel J Jr (ed): Surgical Treatment of the Epilepsies. New York, Raven Press, 1987, pp 541-552.
51. Wolf HK, Wellmer J, Muller M, et al: Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies. J Neuropathol Exp Neurol 1995;54:245-254.
52. Costantino A, Vinters HV: A pathologic correlate of the "steal" phenomenon in a patient with cerebral arteriovenous malformation. Stroke 1985;17:103-106.
53. Bleck TP, Morrell F, Bergen D, et al: Neuropathologic analysis of tissue excised during cortigraphically guided seizure focus resections. Epilepsia 1985;26:535.
54. Drigo P, Mammi I, Battistella PA, et al: Familial cerebral, hepatic and retinal cavernous angiomas: A new syndrome. Childs Nerv Syst 1994;10:205-209.
55. Lemire RL, Loeser JD, Leech RW, Alvord EC Jr (eds): Normal and abnormal development of the human nervous system. Hagerstown, MD, Harper and Row, 1975, pp 331-334.
56. de Volder AG, Gadisseaux JF, Michel CJ, et al: Brain glucose utilization in band heterotopia: Synaptic activity of double cortex. Pediatr Neurol 1994;11:290-294.
57. Lyon G, Adams RD, Kolodny EH (eds): Neurology of Hereditary Metabolic Diseases of Children, ed 2. New York, McGraw Hill, 1996, pp 303-309.
58. Cervos-Navarro J, Urich H (eds): Metabolic and Degenerative Diseases of the Central Nervous System. San Diego, Academic Press, 1995 pp 601-602, 683-684, 689-706.
59. Chintagumpala M, Armstrong D, Nelson T, et al: Mixed glial tumors, gangliogliomas and dysembryoplastic neuroepithelial tumors in children. Pediatr Neurosurg 1996;24:306-313.
60. Bhattacharjee MD, Armstrong DL, Vogel H, Cooley LD: Cytogenetic analysis of 120 primary pediatric brain tumors with review of the literature. Cancer Genet Cytogenet 1997;97:39-53.
61. Louis DN, Seizinger BR, Cavenee WK: Molecular genetics, basis of cerebral glioma, in Apuzzo MLJ (ed): Benign Cerebral Glioma. Park Ridge, American Association of Neurologic Surgeons, 1995, pp 163-180.
62. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System. Baltimore, Williams & Wilkins, 1989.
63. Lang FF, Epstein FJ, Ransohoff J, et al: Central nervous system gangliogliomas. Part 2: Clinical outcome. J Neurosurg 1993;79:867-873.
64. Jaffy PB, Mundt AJ, Baunoch D, et al: The clinical significance of extracellular matrix in gangliogliomas. J Neuropathol Exp Neurol 1996;55:1246-1252.
65. Sloviter RS: Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: Localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol 1989;280:183-196.
66. Daumas-Duport, Scheithauer BW, Chodkiewicz JP, et al: Dysembryoplastic neuroepithelial tumor: A surgically curable tumor of young patients with intractable partial seizures. Neurosurgery 1988;23:545-555.
67. Taratuto AL, Monges L, Lylyk P, Leiguarda R: Superficial cerebral astrocytoma attached to dura: Report of six cases in infants. Cancer 1985;54:2506-2512.
68. Rodriguez ML, Chandrarma P: The pathology of benign cerebral astrocytomas, in Apuzzo MLJ (ed): Benign Cerebral Glioma, vol 1. Park Ridge, American Association of Neurological Surgeons, 1995, pp 55-83.
69. Van den Berg SR: Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol 1993;3:275-281.
70. Van den Berg SR, May EE, Rubinstein LJ, et al: Desmoplastic supratentorial subepithelial tumors of infancy with divergent patiential desmoplastic infantile gangliogliomas: Report of tumors in infancy with distinctive embryonal tumor with favorable prognosis. J Neurosurg 1987;66:58-71.
71. Sawyer JR, Thomas EL, Roloson GJ, et al: Telomeric associations evolving to ring chromosomes in a recurrent pleomorphic xanthoastrocytoma. Cancer Genet Cytogenet 1990;60:152-157.
72. Macaulay RJB, Jay V, Hoffman HJ, Becker LE: Increased mitotic activity as a negative prognostic indicator in pleomorphic zanthoastrocytoma. Neurosurgery 1993;79:761-768.
73. Kepes JJ, Rubinstein LJ, Eng LJ: Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosis: A study of 12 cases. Cancer 1979;44:1839-1852.
74. Nakamura Y, Becker LE: Subependymal giant-cell tumor: Astrocytic or neuronal? Acta Neuropathol 1983;60:271-277.
75. Fujiwara S, Takaki T, Hikata T, Nishio S: Subependymal giant cell astrocytoma associated with tuberous sclerosis: Do subependymal nodules grow? Childs Nerv Syst 1989;5:40-44.
76. Norman MG, Schoene WC: The ultrastructure of Sturge Weber disease. Acta Neuropathol 1977;37:199-204.
77. Hoffman HJ, Hendrick EB, Dennis M, Armstrong D: Hemispherectomy for Sturge Weber syndrome. Childs Brain 1979;5:233-248.
78. Richardson EP Jr: Pathology of tuberous sclerosis, neuropathologic aspects. Ann N Y Acad Sci 1991;615:128-139.
79. Armstrong DD: Neonatal encephalopathies, in Duckett S (ed): Pediatric Neuropathology. Baltimore, Williams & Wilkins, 1995, pp 334-351.
80. Azzarelli B, Meade P, Muller J: Hypoxic lesions in areas of primary myelination. A distinct pattern in cerebral palsy. Childs Brain 1980;7:132-145.
81. Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM: Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol 1991;7:333-341.
82. Jellinger K: Giant cell granulomatous angiitis of the central nervous system. J Neurol 1977;215:175-190.
83. Yamashita M, Oka K, Tanaka K: Histopathology of the vascular networks in Moya Moya disease. Stroke 1983;14:50-58.
84. Lorente de No R: Studies on the structure of the cerebral cortex. II: Continuation of the study of the ammonic system. J Psychol Neurol 1934;46:113-177.
85. Kotagal S, Peterson PL, Martens ME, et al: Impaired NADH-CoQ reductase activity in a child with Moyamoya syndrome. Pediatr Neurol 1988;4:241-244.
86. Calciolari G, Perlman JM, Volpe JJ: Seizures in the neonatal intensive care unit of the 1980's, types, etiologies, timing. Clin Pediatr 1988;27:119-123.
87. Mizrahi E, Kellaway P: Characterization and classification of neonatal seizures. Neurology 1987;37:1837-1844.
88. Bell WE, McCormick WF, Markowitz M (eds): Neurologic Infections in Children. Philadelphia, WB Saunders, 1981, pp 283-468.
89. Perlman JM, Argyle C: Lethal cytomegalovirus infection in preterm infants, clinical, radiological and neuropathological findings. Ann Neurol 1992;31:64-68.
90. Hsu HW, Grady GF, Masguire JH, et al: Newborn screening for congenital toxoplasma infections; five year experience in Massachusetts, USA. Scand Infect Dis 1992;84:59-64.
91. Lowichik A, Siegel JD: Parasitic infections of the central nervous system in children. Part 1: Congenital infections and meningoencephalitis. J Child Neurol 1995;10:4-17.
92. Scaravilli F: Parasitic and fungal infections, in Adams JH, Duchen LW (eds): Greenfield's Neuropathology. New York, Oxford University Press, 1992, pp 400-446.
93. Bruton CJ: The Neuropathology of Temporal Lobe Epilepsy. Oxford, Oxford University Press, Maudsley Monographs #31, 1988.
94. Sommer W: Erkrankung des Ammonshorns als aetiologisches Moment der Epilepsie. Arch Psychiat Nervenkr 1880;10:631-675.
95. Bratz E: Ammonshornbefunde bei Epileptikern. Arch Psychiat Nervenkr 1899;32:820-835.
96. Margerison JH, Corsellis JAN: Epilepsy and the temporal lobes: A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-530.
97. Falconer MA, Taylor DC: Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis. Arch Neurol 1968;19:353-361.
98. Earle KM, Baldwin M, Penfield W: Incisural sclerosis and temporal lobe seizures produced by hippocampal herniation at birth. Arch Neurol Psychiatry 1953;69:27-42.
99. Gastaut H, Toga M, Roger J, Gibson WC: A correlation of clinical, electroencephalographic and anatomical findings in nine autopsied cases of "temporal lobe epilepsy." Epilepsia 1959;1:56-85.
100. Mathieson G: Pathologic aspects of epilepsy with special reference to the surgical pathology of focal cerebral seizures. Adv Neurol 1975;8:107-138.
101. Babb TL, Brown WJ: Pathological findings in epilepsy, in Engel J Jr (ed): Surgical Treatment of the Epilepsies. New York, Raven Press, 1987, pp 511-540.
102. Armstrong DD: The neuropathology of temporal lobe epilepsy. J Neuropathol Exp Neurol 1993;52:433-443.
103. Armstrong DD, Bruton CJ: Postscript: What terminology is appropriate for tissue pathology? How does it predict outcome? in Engel J Jr (ed): Surgical Treatment of the Epilepsies. New York, Raven Press, 1987, pp 541-552.
104. Mathern GW, Pretorius JK, Babb TL: Influence of the type of initial precipitating injury and at what age it occurs on course and outcome in patients with temporal lobe seizures. J Neurosurg 1995;24:259-288.
105. Cascino GD, Jack CR, Parisi JT, et al: Magnetic resonance imaging based volume studies in temporal lobe epilepsy: Pathologic correlations. Ann Neurol 1991;30:31-36.
106. Houser CR: Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res 1990;535:195-204.
107. Green RC, Blume HW, Kupferschmid SB, Mesulam M: Alterations of hippocampal acetylcholinesterase in human temporal lobe epilepsy. Ann Neurol 1989;26:347-351.
108. Robbins RJ, Brines ML, Kim JH: A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann Neurol 1991;29:325-332.
109. Sloviter RS, Sollas AL, Barbaro NM, Laxer KD: Calcium-binding protein (calbinden-D28K) and parvalbumin immunochemistry in the normal and epileptic human hippocampus. J Comp Neurol 1991;308:381-396.
110. Zhu Z, Armstrong DL, Grossman RG, Hamilton WJ: Tyrosine hydroxylase-immunoreactive neurons in the temporal lobe in complex partial seizures. Ann Neurol 1990;27:564-572.
111. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD: Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 1989;495:387-395.
112. Geddes JW, Cahan LD, Cooper SM, et al: Altered distribution of excitatory amino acid receptors in temporal lobe epilepsy. Exp Neurol 1990;108:214-220.
113. Munoz DG: The distribution of chromogranin A-like immunoreactivity in the human hippocampus coincides with the pattern of resistance to epilepsy-induced neuronal damage. Ann Neurol 1990;27:266-275.
114. Represa A, Robain O, Tremblay E, Ben-Ari Y: Hippocampal plasticity in childhood epilepsy. Neurosci Lett 1989;99:351-355.